文献速递血栓与止血

血友病B基因治疗:意大利照护实施模式提案

Gene therapy for people with hemophilia B: a proposed care delivery model in Italy.
PubMed 文献 · J Thromb Haemost · 2024-08-22

意大利血友病专家组通过叙述性文献综述与虚拟会议讨论,围绕血友病B基因治疗在意大利的实施提出照护模式,涵盖Hub and Spoke组织架构、多学科团队角色、实验室监测、患者全程管理及安全性与结局指标识别,并提出患者筛选清单。

要点

  • 文章强调应遵循Hub and Spoke组织模式实施血友病B基因治疗。
  • 文章阐明多学科团队中各专业人员的角色以促进患者参与、管理与留存。
  • 文章提出应进行实验室检测用于患者筛选与随访,并提出辅助患者识别的清单。

核心结论

  • 确保中心具备适当组织、设备与培训,以充分筛选患者、实施基因治疗并开展随访至关重要。

研究设计与样本

  • 意大利血友病专家组开展的叙述性文献综述,并在虚拟会议中讨论血友病B基因治疗在意大利实施的关键方面。

主要发现

  • 文章强调需遵循Hub and Spoke组织模式,并阐明多学科团队中各专业人员的角色以促进患者参与、管理与留存。
  • 文章强调需进行实验室检测用于患者筛选与随访,并提出辅助患者识别的清单。
  • 文章考虑了意大利血友病中心的需求以确保照护实施模式高效落地。

临床怎么用

  • 文章强调应遵循Hub and Spoke组织模式实施血友病B基因治疗。
  • 文章强调应进行实验室检测用于患者筛选与随访,并提出清单辅助患者识别。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gene therapy is designed to provide people with hemophilia B with a steady and elevated factor (F)IX activity, thereby strengthening protection and relieving the burden of frequent replacement therapy infusions. The European Medicines Agency has approved gene therapy for the severe and moderately severe forms of hemophilia B that uses the FIX-Padua variant (etranacogene dezaparvovec). OBJECTIVES: The aim was to provide a document dedicated to hemophilia B gene therapy and give a comprehensive overview of the topic. METHODS: An Italian group of experts in hemophilia carried out a narrative review of the literature and discussed during a virtual meeting several key aspects of the delivery of this treatment in Italy. The discussion covered the organizational model, the role of the multidisciplinary team, the laboratory surveillance, and the patient's journey, from the follow-up to the identification of safety issues and outcome measures. RESULTS: This article highlights the need to follow the Hub and Spoke organizational model and sheds light on the role of each professional figure within the multidisciplinary teams to favor patient engagement, management, and retention. Moreover, this article stresses the need to perform laboratory tests for patient screening and follow-up and proposes a checklist to help patient identification. Finally, the needs of Italian hemophilia centers have been considered to ensure an efficient implementation of the care delivery model. CONCLUSION: It is crucial to ensure that centers are appropriately organized, equipped, and trained to adequately select patients, deliver the gene therapy, and perform follow-up.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Castaman G, Di Minno G, Simioni P, et al. Gene therapy for people with hemophilia B: a proposed care delivery model in Italy. J Thromb Haemost. 2024. PMID: 39173877. doi:10.1016/j.jtha.2024.07.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。